🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Eli Lilly and Company

LLY Healthcare
$1,136.11 $-2.17 (-0.19%)
Market Cap: $1.01 T
Gurus Holding
21
Popularity Rank
#29
% of Shares Held
0.85%
Net Activity (Q2 2026)
+$390.27 M

Guru Ownership Trend

Guru Analysis for Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 21 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.63 B.

Top institutional holders include Ken Fisher and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $390.27 M net inflow during the quarter.

Recent activity highlights Catherine Wood who increased their stake by 509.5%. Conversely, Steven Cohen reduced exposure by 89.1%.

Key Holders

Top 5 by Value

$6.07 B
$1.24 B
$892.34 M
$386.37 M
$104.38 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$689.79 M
Total Buy Value
New Buys 2
Additions 10
-$299.53 M
Total Sell Value
Reductions 7
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
7
Net Buyers
12

FAQs for Eli Lilly and Company (LLY)

Major holders include Ken Fisher ($6.07 B), Cliff Asness ($1.24 B), Jeremy Grantham ($892.34 M). According to the latest reported data, 21 tracked investment managers collectively hold approximately 7.6 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $390.27 M, with 12 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 0 fully exited LLY. The total reported sell value was $299.53 M.

Yes, 2 managers opened new positions in LLY, and 10 increased their existing holdings. The total reported buy value was $689.79 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.81% Add 4.6% 5,063,516 $6.07 B Q2 2026
0.43% Add 21.1% 1,035,605 $1.24 B Q2 2026
2.01% Reduce -0.8% 743,966 $892.34 M Q2 2026
3.54% Reduce -1.3% 322,129 $386.37 M Q2 2026
0.43% Add 22.9% 87,023 $104.38 M Q2 2026
0.60% Add 509.5% 77,254 $92.66 M Q2 2026
1.26% New Buy 57,771 $69.29 M Q2 2026
0.20% Add 37.8% 45,332 $54.37 M Q2 2026
0.05% Reduce -75.2% 30,885 $37.04 M Q2 2026
0.29% Add 3.9% 27,377 $32.84 M Q2 2026
0.04% Reduce -63.7% 26,091 $31.29 M Q2 2026
0.33% 22,199 $26.63 M Q2 2026
0.06% Add 35.8% 21,971 $26.35 M Q2 2026
0.28% New Buy 12,380 $14.85 M Q2 2026
0.01% Reduce -89.1% 10,476 $12.57 M Q2 2026
0.07% Reduce -64.2% 8,250 $9.9 M Q2 2026
0.05% Reduce -3.6% 3,824 $4.59 M Q2 2026
0.65% 2,000 $2.4 M Q2 2026
0.10% Add 3.5% 599 $718,459 Q2 2026
0.04% Add 0.5% 425 $510,008 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form